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Although large-scale genome-wide association studies (GWAS) for obesity traits have
identified more than 400 associated loci from observational studies (Figure 1), we highlight
the fact that currently the number of GWAS for intentional weight change in randomized
controlled trials (RCT) of lifestyle interventions is very scarce.
Future work will include further omics integration and increasing sample size to better
characterize our novel findings.
These subjects were randomized 1:1 to the intervention group and to the control group.
After 1-y of follow-up, mean weight loss in the intervention group (n=238) was -2.81+/-2.7
Kg versus -0.41+/-2.7 Kg in the control group (n=225). There were large inter-individual
differences in weight loss despite the same intervention. So in the intervention group, the
maximum weight loss reached was -13 kg. We first analyzed the genes associated with
weight loss in the whole population (intervention+control group). The top-ranked gene was
the SLC24A2 (Solute Carrier Family 24 Member 2) at the suggestive GWAS level. However,
taking into account that our main interest was the in the intervention group, we present
here the results for the intensive intervention group.
For the intensive intervention group, the top-ranked SNPs associated with 1-y weight loss in
an additive model adjusted for sex and age are presented in Table X. The first three SNPs
were intergenic (the corresponding zoom plots are presented), and the first SNP within a
gene was the rs7007-OAZ3 (ornithine decarboxylase antizyme 3) at P=3x10E-07 (crude) and
2.1x10E-6 (adjusted).
1 Study participants
We have analyzed participants recruited from the PREDIMED Plus-Valencia study (located
on the eastern Mediterranean coast, Spain). This is one of the field centers of the multi-
center PREDIMED Plus study, which is an ongoing trial. This RCT was registered at
https://doi.org/10.1186/ISRCTN89898870. Eligible participants, recruited from several
primary care health facilities in the Valencia field center, were community-dwelling adults
(men, 55–75 years, women, 60–75 years) with a body-mass index (BMI) in the overweight
or obesity range ((BMI) ≥ 27 and <40 kg/m2) and had at least three components of the
metabolic syndrome [58]. In the Valencia field center (located on the eastern
Mediterranean coast), the total number of randomized participants included in the
PREDIMED Plus trial was 465.
Figure 1: Genes associated with weight and obesity-related measures in GWAS from
observational studies (Speliotes et al, Nat Genet. 2010; 42: 937–948)
Table 1 shows the main characteristics of the Predimed-Valencia study participants at
baseline.
Only a few RCT on weight loss have been carried out and recently a GWAS including 2
populations (a Canadian RCT and the Diogenes RCT) was been published (Valsesia et al, Nat
Communications, 2019). Likely, at the transcriptome level, there is a scarcity of
transcriptome-wide association studies (TWAS) of weight loss in RCT. Moreover, this scarcity
is higher for studies including subjects from the Mediterranean countries.
Therefore, our first aim was to undertake a GWAS in overweight/obese subjects from a
Mediterranean population (Spain) after 1-year lifestyle intervention (including an energy
restricted Mediterranean diet plus physical activity) in a RCT to identify genetic variants
associated with weight loss and related outcomes. In addition, as a second aim, we carried
out a TWAS in a subsample of subjects for the same intervention to identify changes in
gene expression and related pathways.
Study participants were randomized 1:1 to the intervention group or the control group. A
Computer-generated random allocation was centrally elaborated in blocks of six subjects
and stratified by sex, age (<65, 65–70, >70) and center. The randomization procedure was
internet-based and blinded to all staff and to the principal investigators of each center. In
the intervention group we evaluated the effect of an intensive weight loss intervention
based on an energy-restricted traditional Mediterranean diet, physical activity promotion
and behavioral support as compared to a usual care intervention consisted only on energy-
unrestricted MedDiet recommendations (control group).
Anthropometric variables were determined by trained staff and follow the PREDIMED Plus
operations protocol detailed in the study Web site (http://www.predimedplus.com/).
Weight and height were measured with calibrated scales and a wall-mounted stadiometer,
respectively. BMI was calculated as the weight in kilograms divided by the height in meters
squared. The waist circumference was measured midway between the lowest rib and the
iliac crest after normal expiration, using an anthropometric tape. We calculated the weight
loss after 1-year intervention in the intensive intervention group and in the control group.
Stratified GWAS were carried out to identify the genes associated with weight loss.
2. Genomic analyses and GWAS
DNA was isolated from blood (buffy-coats), and  high-density genotyping was performed at
the University of Valencia using the Infinium OmniExpress-24 v1.2 BeadChip genotyping
array (Illumina Inc., San Diego, CA, USA), according to the manufacturer’s protocol with
appropriate quality standards.
This array captures 713,599 markers. Allele detection and genotype calling were performed
in the GenomeStudio genotyping module (Illumina, Inc., San Diego, CA, USA). Data cleaning
was performed using standard analysis pipelines implemented in the Phyton programing
language using the Numpy library modules combined with the PLINK. From the initial full
set, those SNPs not mapped on autosomal chromosomes were filtered out.
In addition, SNPs with a minor allele frequency (MAF) < 0.01 or those that deviated from
expected Hardy-Weinberg equilibrium (p < 1.0 × 10−5) were removed. A total of 622,468
SNPs that passed the quality filter remained for further analysis. The total number of
subjects with GWAS genotyping was 448. For GWAS, genetic association analyses were
performed using PLINK v1.9. To evaluate the association of 1-year weight loss with each
SNP, using PLINK, an additive genetic model was fitted (0, 1, or 2 copies of the variant
allele). Coefficients for the minor allele were estimated. Unadjusted and adjusted (for sex
and age or for additional variables) general linear models were fitted. Stratified GWAS
analyses by intervention group were carried out. We used the conventional threshold of p <
5 × 10−8  for genome-wide statistical significance. Since this threshold is very conservative
for a small sample size, SNPs with p-values below 1 × 10−5 were also considered sugges ve 
of genome-wide significance. SNPs were rank-ordered according to the minimum p-value in
the genetic models.
3. RNA isolation and TWAs
RNA was isolated from fresh blood at baseline and after 1-y of follow-up  with the Promega
device and kit. RNA integrity was assayed by means of the 2100 Bioanalyzer with Eukaryote
total RNA Nano Assay (Agilent Technologies, Santa Clara, CA, USA). RNA integrity number
(RIN) served as RNA integrity parameter (selection criteria RIN ≥ 9.0).Microarray
experiments were performed at the Central Research Unit (University of Valencia).
GeneChip Human Gene 2.0 ST Array containing over 41,000 transcripts and represent over
36,000 well-characterized human genes (Affymetrix, Santa Clara, CA, USA) was used for
microarray analysis. The fragmentation of biotinylated cRNA derived from 150 ng of total
RNA was used to hybridize to GeneChips. The hybridization cocktail was incubated
overnight at 45°C while rotating in a hybridization oven. After 16h of hybridization, the
cocktail was removed and the arrays were washed and stained in an Affymetrix GeneChip
Fluidics Station 450, according to the Affymetrix’s protocol. The distribution of fluorescent
material on the array was obtained using GeneChip Scanner 3000 7G (Affymetrix, Santa
Clara, CA, USA). GeneChip Operating Software supplied by Affymetrix was used to
generate.CEL files. Partek Genomic suite was used for gene expression analysis.
Multivariate models were used to adjust for potential confounders including batch effect,
sex, age, leukocyte counts, etc. TWAS analyses were carried out in a subsample of individual
(n=48). In the intervention group (n=36), we selected subjects with a higher weight loss
(mean 5 kg), and in the control group (n=we selected subjects paired by age and sex with
the intervention group but without losing weight.
Methods
Table 1: General features of the Predimed-Valencia study participants
Total (n=465) Men (n=198) Women (n=267) P
Age (years) 65.1±0.2 63.9±0.4 66.1±0.3 <0.001
Weight (Kg) 84.5±0.7 92.8±1.0 78.0±0.6 <0.001
BMI (Kg/m2) 32.4±0.2 32.3±0.2 32.5±0.2 0.629
Waist circumference (cm) 106.1±0.5 111.2±0.6 102.0±0.6 <0.001
SBP (mm Hg) 141.6±0.9 143.8±1.3 139.9±1.2 0.026
DBP (mm Hg) 81.0±0.5 82.6±0.7 79.7±0.6 0.002
Total cholesterol (mg/dL) 196.4±1.8 188.3±2.8 202.6±2.3 <0.001
LDL-C (mg/dL) 125.0±1.5 121.6±2.4 127.7±1.9 0.044
HDL-C (mg/dL) 51.5±0.5 47.5±0.8 54.7±0.7 <0.001
Triglycerides (mg/dL) 141.6±2.9 138.2±3.8 144.3±4.2 0.296
Fasting glucose (mg/dL) 112.5±1.3 112.8±2.0 112.3±1.7 0.862
Ornithine decarboxylase (ODC) antizyme protein that negatively regulates ODC activity and
intracellular polyamine biosynthesis and uptake in response to increased intracellular
polyamine levels. Currenty this gene as well as the polyamines are presenting a renewed
interest.
The Second top-ranked gene was the DNAH11 (Dynein, axonemal, heavy chain 11). Encodes
a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. In the
TWAS, we obtained as the top-ranked gene differentially expressed from baseline to 1-y
follow-up in the intervention group, the DYNLT1 gene.
There are several works showing the connection between cilia and autophagy and cilia and
obesity.
Although these results are still preliminary, we have obtained as top-ranked the DYNLT1
both in the GWAS and in the TWAS analysis. More work is needed in order to integrate
genomics and transcriptomics results, but these preliminary results are suggesting a role of
dyneins and the cilia in weight loos. In addition, when we carried out a pathway analysis in
the TWAS, we obtained that several pathways related with the autophagy were among the
top-ranked.
